Trial intelligence / Profile preview

Larotrectinib in pediatric patients with advanced solid or primary CNS tumors

NL-OMON54602Phase 2Recruiting

Sponsor

Bayer Consumer Health

Start

Jul 2019

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1